Home LiteratureArticle Details
PMID: 2461824 Published · ppublish English Journal Article

Quantity of anti-leucoprotease relative to alpha 1-proteinase inhibitor in peripheral airspaces of the human lung.

Clinical science (London, England : 1979) ·Vol. 75 ·No. 4 ·1988-10-00 ·Pages 351-3

Kramps JA, Franken C, Dijkman JH

Abstract

1. Peripheral airspaces were selectively lavaged using balloon-tipped catheters of 2 mm diameter. 2. Molar anti-leucoprotease/alpha 1-proteinase inhibitor ratios as determined in these lavage fluids by enzyme immunoassays ranged from 0.02 to 0.14 (mean 0.08). 3. These data indicate that peripheral airspaces contain minor amounts of anti-leucoprotease relative to alpha 1-proteinase inhibitor. This observation does not necessarily mean that anti-leucoprotease is of minor importance in protecting the lung interstitium.

MeSH Terms
Acute-Phase Proteins/metabolism Adult Aged Blood Proteins/metabolism Bronchoalveolar Lavage Fluid/enzymology Enzyme-Linked Immunosorbent Assay Female Humans Male Middle Aged Protease Inhibitors/metabolism Proteinase Inhibitory Proteins, Secretory Proteins alpha 1-Antitrypsin
Chemicals
Acute-Phase Proteins Blood Proteins Protease Inhibitors Proteinase Inhibitory Proteins, Secretory Proteins alpha 1-Antitrypsin
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Kramps J A
Department of Pulmonology, University Hospital, Leiden, The Netherlands.
Franken C
Dijkman J H
Article Info
Journal
Clinical science (London, England : 1979)
Abbr.
Clin Sci (Lond)
ISSN
0143-5221
Published
1988-10-00
Pages
351-3
Language
English
Region
England
NLM ID
7905731
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]